The endocannabinoid system and the treatment of mood and anxiety disorders.
paper
Cited
Public
Unavailable
- Authors
- Hill, Matthew N; Gorzalka, Boris B
- Year
- 2009
- Journal
- CNS & neurological disorders drug targets
- PMID
- 19839936
- DOI
- 10.2174/187152709789824624
The central endocannabinoid system is a neuroactive lipid signalling system in the brain which acts to control neurotransmitter release. The expression patterns of this system throughout limbic regions of the brain ideally situate it to exert regulatory control over emotional behaviour, mood and stress responsivity. A growing body of evidence unequivocally demonstrates that deficits in endocannabinoid signalling may result in depressive and anxiogenic behavioral responses, while pharmacological augmentation of endocannabinoid signalling can produce both antidepressive and anxiolytic behavioral responses. The aim of this review is to summarize current knowledge of the role of the endocannabinoid system in the etiology and treatment of mood and anxiety disorders, such as depression, anxiety and post-traumatic stress disorder. Collectively, both clinical and preclinical data argue that cannabinoid receptor signalling may be a realistic target in the development of a novel class of agent for the pharmacotherapy of mood and anxiety disorders.
No figures extracted from this document.
No chunks β full text not yet ingested.
No entities extracted from this document yet.
No uploaded files.
Not in any collection.
No citations found.
In this knowledge base
External
| Title | Authors | Journal | Year | Link |
|---|---|---|---|---|
| Schisandra chinensis lignans exerts endocannabinoids-like antidepressive effect: The phagocytotic relationship of activated CB2R-mediated M2 microglia and "stressed-but-viable" neuron. | Wang J et al. | β | 2025 | β |
| The Cost Effectiveness of Adjunctive Medical Cannabis Therapy in the Treatment of Moderate Post-Traumatic Stress Disorder. | Doucette ML et al. | β | 2025 | β |
| The Effects of Indirect and Direct Modulation of Endocannabinoid System Function on Anxiety-Related Behavior in Mice Assessed in the Elevated Plus Maze Test. | Kruk-Slomka M et al. | β | 2025 | β |
| Endocannabinoids and Stress-Related Neurospsychiatric Disorders: A Systematic Review and Meta-Analysis of Basal Concentrations and Response to Acute Psychosocial Stress. | Gowatch LC et al. | β | 2024 | β |
| Impact of Medical Cannabis Treatment on Healthcare Utilization in Patients with Post-traumatic Stress Disorder: A Retrospective Cohort Study | Doucette ML et al. | β | 2024 | β |
| Proceedings of the 2024 Cannabis Clinical Outcomes Research Conference. | Goodin AJ et al. | β | 2024 | β |
| The endocannabinoid system is involved in the anxiety-like behavior induced by dual-frequency 2.65/0.8βGHz electromagnetic radiation in mice. | Xue T et al. | β | 2024 | β |
| Could serum endocannabinoid and N-acylethanolamine levels be important in bipolar disorder? | Topuz RD et al. | β | 2023 | β |
| Endocannabinoid and psychological responses to acute resistance exercise in trained and untrained adults. | Sirotiak Z et al. | β | 2023 | β |
| Endocannabinoid System and Exogenous Cannabinoids in Depression and Anxiety: A Review. | Hasbi A et al. | β | 2023 | β |
| Neuro-Gastro-Cannabinology: A Novel Paradigm for Regulating Mood and Digestive Health. | Turco F et al. | β | 2023 | β |
| An innovative electrochemical immuno-platform towards ultra-sensitive monitoring of 2-arachidonoyl glycerol in samples from rats with sleep deprivation: bioanalysis of endogenous cannabinoids using biosensor technology. | Kohansal F et al. | β | 2022 | β |
| Assessment of clinical outcomes of medicinal cannabis therapy for depression: analysis from the UK Medical Cannabis Registry. | Mangoo S et al. | β | 2022 | β |
| Effects of super-class cannabis terpenes beta-caryophyllene and alpha-pinene on zebrafish behavioural biomarkers. | Johnson A et al. | β | 2022 | β |
| Examining the Use of Antidepressants for Adolescents with Depression/Anxiety Who Regularly Use Cannabis: A Narrative Review. | Hen-Shoval D et al. | β | 2022 | β |
| The acute effects of cannabidiol on emotional processing and anxiety: a neurocognitive imaging study. | Bloomfield MAP et al. | β | 2022 | β |
| The endocannabinoid system in borderline personality disorder and antisocial personality disorder: A scoping review. | Ho W et al. | β | 2022 | β |
| Design, synthesis and <i>inΒ vitro</i> and <i>inΒ vivo</i> biological evaluation of flurbiprofen amides as new fatty acid amide hydrolase/cyclooxygenase-2 dual inhibitory potential analgesic agents. | Deplano A et al. | β | 2021 | β |
| Endocannabinoids and Precision Medicine for Mood Disorders and Suicide. | Pinna G | β | 2021 | β |
| Endocannabinoids, cannabinoids and the regulation of anxiety. | Petrie GN et al. | β | 2021 | β |
| Exogenous Antioxidants Impact on UV-Induced Changes in Membrane Phospholipids and the Effectiveness of the Endocannabinoid System in Human Skin Cells. | GΔgotek A et al. | β | 2021 | β |
| Sex Differences in a Rat Model of Peripheral Neuropathic Pain and Associated Levels of Endogenous Cannabinoid Ligands. | Boullon L et al. | β | 2021 | β |
| The cannabinoid system and microglia in health and disease. | Duffy SS et al. | β | 2021 | β |
| A Guide to Targeting the Endocannabinoid System in Drug Design. | Stasiulewicz A et al. | β | 2020 | β |
| Kaempferol Facilitated Extinction Learning in Contextual Fear Conditioned Rats via Inhibition of Fatty-Acid Amide Hydrolase. | Ahmad H et al. | β | 2020 | β |
| Neuropeptide Y and cannabinoids interaction in the amygdala after exposure to shock and reminders model of PTSD. | Maymon N et al. | β | 2020 | β |
| News Feature: Cannabis and the adolescent brain. | Shen H | β | 2020 | β |
| Pharmacologic Characterization of JNJ-42226314, [1-(4-Fluorophenyl)indol-5-yl]-[3-[4-(thiazole-2-carbonyl)piperazin-1-yl]azetidin-1-yl]methanone, a Reversible, Selective, and Potent Monoacylglycerol Lipase Inhibitor. | Wyatt RM et al. | β | 2020 | β |
| Brain permeant and impermeant inhibitors of fatty-acid amide hydrolase suppress the development and maintenance of paclitaxel-induced neuropathic pain without producing tolerance or physical dependence in vivo and synergize with paclitaxel to reduce tumor cell line viability in vitro. | Slivicki RA et al. | β | 2019 | β |
| Cannabis and the Anxiety of Fragmentation-A Systems Approach for Finding an Anxiolytic Cannabis Chemotype. | Kamal BS et al. | β | 2018 | β |
| Changes in Gene Expression in the Locus Coeruleus-Amygdala Circuitry in Inhibitory Avoidance PTSD Model. | Sabban EL et al. | β | 2018 | β |
| Endocannabinoid and Opioid System Interactions in Exercise-Induced Hypoalgesia. | Crombie KM et al. | β | 2018 | β |
| Palmitoylethanolamide as adjunctive therapy in major depressive disorder: A double-blind, randomized and placebo-controlled trial. | Ghazizadeh-Hashemi M et al. | β | 2018 | β |
| Prefrontal endocannabinoids, stress controllability and resilience: A hypothesis. | Worley NB et al. | β | 2018 | β |
| Psychobiological Responses to Aerobic Exercise in Individuals With Posttraumatic Stress Disorder. | Crombie KM et al. | β | 2018 | β |
| Sex differences in the effect of cannabinoid type 1 receptor deletion on locus coeruleus-norepinephrine neurons and corticotropin releasing factor-mediated responses. | Wyrofsky RR et al. | β | 2018 | β |
| Cannabidiol disrupts the consolidation of specific and generalized fear memories via dorsal hippocampus CB<sub>1</sub> and CB<sub>2</sub> receptors. | Stern CAJ et al. | β | 2017 | β |
| Cannabinoids prevent the differential long-term effects of exposure to severe stress on hippocampal- and amygdala-dependent memory and plasticity. | Shoshan N et al. | β | 2017 | β |
| Effects of Intermittent Alcohol Exposure on Emotion and Cognition: A Potential Role for the Endogenous Cannabinoid System and Neuroinflammation. | Sanchez-Marin L et al. | β | 2017 | β |
| Monoglyceride lipase as a drug target: At the crossroads of arachidonic acid metabolism and endocannabinoid signaling. | Grabner GF et al. | β | 2017 | β |
| Neurobiology of Chronic Stress-Related Psychiatric Disorders: Evidence from Molecular Imaging Studies. | Davis MT et al. | β | 2017 | β |
| Nutritional n-3 PUFA Deficiency Abolishes Endocannabinoid Gating of Hippocampal Long-Term Potentiation. | Thomazeau A et al. | β | 2017 | β |
| Pharmacological inhibition of FAAH activity in rodents: A promising pharmacological approach for psychological-cardiac comorbidity? | Carnevali L et al. | β | 2017 | β |
| Role of the Endocannabinoid System in the Pathophysiology of Schizophrenia. | Fakhoury M | β | 2017 | β |
| The effects of cannabinoid receptors activation and glucocorticoid receptors deactivation in the amygdala and hippocampus on the consolidation of a traumatic event. | Shoshan N et al. | β | 2017 | β |
| The role of polyunsaturated fatty acids and GPR40 receptor in brain. | Khan MZ et al. | β | 2017 | β |
| Cannabinoids and post-traumatic stress disorder: clinical and preclinical evidence for treatment and prevention. | Mizrachi Zer-Aviv T et al. | β | 2016 | β |
| Cannabinoids reverse the effects of early stress on neurocognitive performance in adulthood. | Alteba S et al. | β | 2016 | β |
| Developmental regulation of fear learning and anxiety behavior by endocannabinoids. | Lee TT et al. | β | 2016 | β |
| Endocannabinoid CB1 receptor activation upon global ischemia adversely impact recovery of reward and stress signaling molecules, neuronal survival and behavioral impulsivity. | Knowles MD et al. | β | 2016 | β |
| Endocannabinoid-Mediated Plasticity in Nucleus Accumbens Controls Vulnerability to Anxiety after Social Defeat Stress. | Bosch-Bouju C et al. | β | 2016 | β |
| Interactions Between Anandamide and Corticotropin-Releasing Factor Signaling Modulate Human Amygdala Function and Risk for Anxiety Disorders: An Imaging Genetics Strategy for Modeling Molecular Interactions. | Demers CH et al. | β | 2016 | β |
| Neurobiological Interactions Between Stress and the Endocannabinoid System. | Morena M et al. | β | 2016 | β |
| Targeting the endocannabinoid system to treat anxiety-related disorders. | Korem N et al. | β | 2016 | β |
| The effects anandamide signaling in the prelimbic cortex and basolateral amygdala on coping with environmental stimuli in rats. | Aliczki M et al. | β | 2016 | β |
| Antidepressant-like effects of oleoylethanolamide in a mouse model of chronic unpredictable mild stress. | Jin P et al. | β | 2015 | β |
| Anxiety disorders and GABA neurotransmission: a disturbance of modulation. | Nuss P | β | 2015 | β |
| Cannabis use and mental health-related quality of life among individuals with depressive disorders. | Aspis I et al. | β | 2015 | β |
| CB1 receptors modulate affective behaviour induced by neuropathic pain. | RΓ‘cz I et al. | β | 2015 | β |
| Genetic deletion of monoacylglycerol lipase leads to impaired cannabinoid receptor CBβR signaling and anxiety-like behavior. | Imperatore R et al. | β | 2015 | β |
| Involvement of norepinephrine and serotonin system in antidepressant-like effects of oleoylethanolamide in the mice models of behavior despair. | Yu HL et al. | β | 2015 | β |
| Is there a "metabolic-mood syndrome"? A review of the relationship between obesity and mood disorders. | Mansur RB et al. | β | 2015 | β |
| Monoacylglycerol lipase (MGLL) polymorphism rs604300 interacts with childhood adversity to predict cannabis dependence symptoms and amygdala habituation: Evidence from an endocannabinoid system-level analysis. | Carey CE et al. | β | 2015 | β |
| Brain region-specific changes in N-acylethanolamine contents with time of day. | Liedhegner ES et al. | β | 2014 | β |
| Cannabinoid modulation of alpha2 adrenergic receptor function in rodent medial prefrontal cortex. | Cathel AM et al. | β | 2014 | β |
| Interaction between Antagonist of Cannabinoid Receptor and Antagonist of Adrenergic Receptor on Anxiety in Male Rat. | Komaki A et al. | β | 2014 | β |
| Piperazine and piperidine carboxamides and carbamates as inhibitors of fatty acid amide hydrolase (FAAH) and monoacylglycerol lipase (MAGL). | Korhonen J et al. | β | 2014 | β |
| Pre- and postsynaptic type-1 cannabinoid receptors control the alterations of glutamate transmission in experimental autoimmune encephalomyelitis. | Musella A et al. | β | 2014 | β |
| Psychiatric neural networks and neuropharmacology: Selected advances and novel implications. | Ghanemi A | β | 2014 | β |
| Tales from the dark side: do neuromodulators of drug withdrawal require changes in endocannabinoid tone? | Oleson EB et al. | β | 2014 | β |
| The neurobiological bases of memory formation: from physiological conditions to psychopathology. | Bisaz R et al. | β | 2014 | β |
| Ξ²-Caryophyllene, a CB2 receptor agonist produces multiple behavioral changes relevant to anxiety and depression in mice. | Bahi A et al. | β | 2014 | β |
| Behavioral responses to acute and sub-chronic administration of the synthetic cannabinoid JWH-018 in adult mice prenatally exposed to corticosterone. | MacrΓ¬ S et al. | β | 2013 | β |
| Cannabidiol exhibits anxiolytic but not antipsychotic property evaluated in the social interaction test. | Almeida V et al. | β | 2013 | β |
| Cannabinoid facilitation of fear extinction memory recall in humans. | Rabinak CA et al. | β | 2013 | β |
| Cannabinoid modulation of chronic mild stress-induced selective enhancement of trace fear conditioning in adolescent rats. | Reich CG et al. | β | 2013 | β |
| Chronic cannabinoid exposure reduces phencyclidine-induced schizophrenia-like positive symptoms in adult rats. | Spano MS et al. | β | 2013 | β |
| Evaluation of psychometric properties of the Chinese Mandarin version State-Trait Anxiety Inventory Y form in Taiwanese outpatients with anxiety disorders. | Ma WF et al. | β | 2013 | β |
| Inflammatory cytokines in depression: neurobiological mechanisms and therapeutic implications. | Felger JC et al. | β | 2013 | β |
| NESS06SM reduces body weight with an improved profile relative to SR141716A. | Mastinu A et al. | β | 2013 | β |
| Reductions in circulating endocannabinoid levels in individuals with post-traumatic stress disorder following exposure to the World Trade Center attacks. | Hill MN et al. | β | 2013 | β |
| Targeting the endocannabinoid system to treat haunting traumatic memories. | Akirav I | β | 2013 | β |
| The endocannabinoid system as a possible target to treat both the cognitive and emotional features of post-traumatic stress disorder (PTSD). | Trezza V et al. | β | 2013 | β |
| Understanding resilience. | Wu G et al. | β | 2013 | β |
| Brain CBβ receptor expression following lipopolysaccharide-induced inflammation. | Hu H et al. | β | 2012 | β |
| Cannabinoid modulation of subgenual anterior cingulate cortex activation during experience of negative affect. | Rabinak CA et al. | β | 2012 | β |
| Cannabinoids and emotionality: a neuroanatomical perspective. | McLaughlin RJ et al. | β | 2012 | β |
| Cannabinoids and monoamine neurotransmission with focus on monoamine oxidase. | FiΕ‘ar Z | β | 2012 | β |
| CB1 receptor-deficient mice as a model for depression. | Valverde O et al. | β | 2012 | β |
| Characterization of the effects of reuptake and hydrolysis inhibition on interstitial endocannabinoid levels in the brain: an in vivo microdialysis study. | Wiskerke J et al. | β | 2012 | β |
| Differential effects of single versus repeated alcohol withdrawal on the expression of endocannabinoid system-related genes in the rat amygdala. | Serrano A et al. | β | 2012 | β |
| Endocannabinoids and the cardiovascular response to stress. | O'Sullivan SE et al. | β | 2012 | β |
| Expression pattern of the cannabinoid receptor genes in the frontal cortex ofΒ mood disorder patients and mice selectively bred for high and low fear. | Choi K et al. | β | 2012 | β |
| Failure to extinguish fear and genetic variability in the human cannabinoid receptor 1. | Heitland I et al. | β | 2012 | β |
| Fatty-acid amide hydrolase polymorphisms and post-traumatic stress disorder after penetrating brain injury. | Pardini M et al. | β | 2012 | β |
| Introduction to the special issue "Pharmacotherapies for the treatment of alcohol abuse and dependence" and a summary of patents targeting other neurotransmitter systems. | Bell RL et al. | β | 2012 | β |
| Is rTMS an effective therapeutic strategy that can be used to treat anxiety disorders? | Machado S et al. | β | 2012 | β |
| Little things on which happiness depends: microRNAs as novel therapeutic targets for the treatment of anxiety and depression. | O'Connor RM et al. | β | 2012 | β |
| Mitigation of post-traumatic stress symptoms by Cannabis resin: a review of the clinical and neurobiological evidence. | Passie T et al. | β | 2012 | β |
| Nutritional n-3 polyunsaturated fatty acids deficiency alters cannabinoid receptor signaling pathway in the brain and associated anxiety-like behavior in mice. | Larrieu T et al. | β | 2012 | β |
| A comparison of independent depression and substance-induced depression in cannabis-, cocaine-, and opioid-dependent treatment seekers. | Dakwar E et al. | β | 2011 | β |
| Early exposure to environmental enrichment alters the expression of genes of the endocannabinoid system. | El Rawas R et al. | β | 2011 | β |
| Enhancement of endocannabinoid signaling with JZL184, an inhibitor of the 2-arachidonoylglycerol hydrolyzing enzyme monoacylglycerol lipase, produces anxiolytic effects under conditions of high environmental aversiveness in rats. | Sciolino NR et al. | β | 2011 | β |
| Inhibition of endocannabinoid catabolic enzymes elicits anxiolytic-like effects in the marble burying assay. | Kinsey SG et al. | β | 2011 | β |
| Modulation of endocannabinoid-mediated long-lasting disinhibition of striatal output by cholinergic interneurons. | Adermark L | β | 2011 | β |
| N-palmitoylethanolamide, an endocannabinoid, exhibits antidepressant effects in the forced swim test and the tail suspension test in mice. | Yu HL et al. | β | 2011 | β |
| Pregabalin influences insula and amygdala activation during anticipation of emotional images. | Aupperle RL et al. | β | 2011 | β |
| The role of cannabinoids in modulating emotional and non-emotional memory processes in the hippocampus. | Akirav I | β | 2011 | β |
| Brain CBβ Receptors: Implications for Neuropsychiatric Disorders. | Roche M et al. | β | 2010 | β |
| Endocannabinoid signalling: has it got rhythm? | Vaughn LK et al. | β | 2010 | β |
| Functional interactions between stress and the endocannabinoid system: from synaptic signaling to behavioral output. | Hill MN et al. | β | 2010 | β |
| Neurobiology of suicidal behavior in post-traumatic stress disorder. | Sher L | β | 2010 | β |
| The endocannabinoid system and psychiatric disorders. | Parolaro D et al. | β | 2010 | β |